2,673
Views
4
CrossRef citations to date
0
Altmetric
Araştırmalar/Original Papers

Türkiye'de Bipolar I Bozukluğu Hastalarının, Sosyodemografik ve Klinik Özellikleri-HOME Çalışması

Sociodemographic and clinical features of patients with bipolar I disorder in Turkey-HOME study

, , , , , & show all
Pages 31-42 | Received 15 Apr 2011, Accepted 22 Dec 2011, Published online: 08 Nov 2016

Kaynaklar

  • Morgan VA, Mitchell PB, Jablensky AV. The epidemiology of bipolar isorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders. Bipolar Disord 2005; 7(4): 326–37.
  • Have M, Volleburgh W, Bijl R, Nolen WA. Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilization): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 2002; 68(2–3): 203–13.
  • Morselli PL, Elgie R, Cesana BM. GAMIAN-Europe/BEAM survey-II: cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style. Bipolar Disord 2004; 6(6): 487–97.
  • Coryell W, Schaftner W, Keller MB, Endicott J, Maser J, Klerman GL. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993; 150(5): 720–7.
  • Harrow M, Goldberg JF, Grossman LS, Herbet Y, Meltzer Y. Outcome in mania: a naturalistic follow-up study. Arch Gen Psychiatry 1990; 47(7): 665–71.
  • Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 2000; 48(6): 445–57.
  • Keck PE Jr, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkinins JM, et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998; 155(5): 646–52.
  • Strakowski SM, Keck PE Jr, McElroy SL, West SA, Sax KW, Hawkins JM, et al. Twelve-month outcome following a first hospitalization for affective psychosis. Arch Gen Psychiatry 1998; 55(1): 49–55.
  • Tohen M, Zarate CA Jr, Hennen J, Khalsa HMK, Strakowski SM, Gebre-Medvin P, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry 2003; 160(12): 2099–107.
  • Strakowski SM, Tsai SY, Delbello MP, Chen CC, Fleck DE, Adler CM, et al. Outcome following a first manic episode: cross-national US and Taiwan comparison. Bipolar Disord 2007; 9(8): 820–27.
  • Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M. Anxiety disorders in 318 bipolar patients: Prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry 2003; 64(3): 331–5.
  • Kessler RC, Rubinow DR, Holmes C, Zhao S. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 1997; 27(5): 1079–89.
  • McElroy SL, Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158(3): 420–6.
  • Pini S, Cassano GB, Simonini E, Savino M, Russo A, Montgomery SA. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord 1997; 42(2–3): 145–53.
  • Tamam L. Bipolar Bozukluk ile Anksiyete Bozukluğu Birlikteliği: Bir Gözden Geçirme. Türk Psikiyatri Dergisi 2007; 18(1): 59–71.
  • Brady KT, Lydiard RB. Bipolar affective disorder and substance abuse. J Clin Psychopharmacol 1992; 12 (Suppl. 1): S17–S22.
  • Regier DA, Farmer ME, Rae DS, Locke BZ, Keith S J, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264(19): 2511–8.
  • Boylan KR, Bieling PJ, Marriott M, Begin H, Young T, MacQueen G. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry 2004; 65(8): 1106–13.
  • Cassano GB, Pini S, Saettoni M, Dell'Osso L. Multiple anxiety disorder comorbidity in patients with moodspectrum disorders with psychotic features. Am J Psychiatry 1999; 156(3): 474–6.
  • Rudd MD, Dahm PF, Rajab MH. Diagnostic comorbidity in persons with suicidal ideation and behavior. Am J Psychiatry 1993; 150(6): 928–34.
  • Oswald P, Souery D, Kasper S, Lecrubier Y, Montgomery SA, Zohar J, et al. Predictive factors of resistance to antidepressants in bipolar depression: results from a European multicentre study. Eur Neuropsychopharmacol 2006; 16 (Suppl. 1): S83.
  • Black DW, Winokur G, Bell S, Nasrallah A, Hulbet J. Complicated mania. Comorbidity and immediate outcome in the treatment of mania. Arch Gen Psychiatry 1988; 45(3): 232–6.
  • Black DW, Hulbert J, Nasrallah A. The effect of somatic treatment and comorbidity on immediate outcome in manic patients. Compr Psychiatry 1989; 30(1): 74–9.
  • Strakowski SM, Tohen M, Stoll AL, Faedda GL, Goodwin DC. Comorbidity in mania at first hospitalization. Am J Psychiatry 1992; 149(4): 554–6.
  • Tsai SM, Chen C, Kuo C, Lee J, Lee H, Strakowski SM. 15-year outcome of treated bipolar disorder. J Affect Disord 2001; 63(1–3): 215–20.
  • Mitchell PB, Slade T, Andrews G. Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey. Psychol Med 2004; 34(5): 777–85.
  • Kora K, Saylan M, Akkaya C, Karamustafalioglu N, Tomruk N, Yasan A, et al. Predictive factors for time to remission and recurrence in patients treated for acute mania: Health outcomes of manic episodes (HOME) study. Prim Care Companion J Clin Psychiatry 2008; 10(2): 114–9.
  • Amerikan Psikiyatri Birliği. Mental Bozuklukların Tanısal ve Sayımsal Elkitabı, Dördüncü Baskı (DSM-IV). Köroğlu E (çev.) Ankara; Hekimler Yayın Birliği, 1994.
  • Karadağ F, Oral T, Aran Yalçın F, Erten E. Young Mani Derecelendirme Ölçeğinin Türkiye'de geçerlik ve güvenilirliği. Türk Psikiyatri Dergisi 2001; 13(2): 107–14.
  • Spearing MK, Post RM, Leverich GS, Brant D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73(3): 159–71.
  • Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–35.
  • Turhan N. Bipolar Bozukluk: Kesitsel Bir Değerlendirme. Yayınlanmamış Uzmanlık tezi, Çukurova Üniversitesi Tıp Fakültesi, Psikiyatri AD, Adana, 2007.
  • Karamustafalıoğlu N, Alpay N, Tomruk B. İki uçlu mizaç bozukluğunda cinsiyet farklılıkları ve tedaviye yansımaları. Anadolu Psikiyatri Dergisi 2004; 5(1): 28–36.
  • Kupka RW, Nolen WA, Altshuler LL, Denikoff KD, Frye MA, Leverich GS, et al. The stanley Foundation Bipolar Network 2. Preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry 2001; 41(Supp. l): S177–S83.
  • Özerdem A, Tunca Z, Kaya N. The relatively good prognosis of bipolar disorders in a Turkish bipolar clinic. J Affect Disord 2001; 64(1): 27–34.
  • Bellantuono C, Barraco A, Rossi A, Goetz I. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy. BMC Psychiatry 2007; 7: 33.
  • Levine J, Chengappa KN, Brar JS, Kupfer DJ. Illness characteristics and their association with prescription patterns for bipolar I disorder. Bipolar Disord 2001; 3(1): 41–9.
  • Mantere O, Suominen K, Leppämäki S, Valtonen A, Arvilommi P, Isometsa E. The clinical characteristics of DSM-IV bipolar I and II disorders: baseline findings from the Jorvi Bipolar Study (JoBS). Bipolar Disord 2004; 6(5): 395–405.
  • Sutton PD, Munson ML. Births, marriages, divorces, and deaths: Provisional data for February 2005. National vital statistics reports; vol 54 no 3. Hyattsville, MD: National Center for Health Statistics, 2005.
  • Uçan Ö. Boşanma Sürecinde Kriz Merkezine Başvuran Kadınların Retrospektif Olarak Değerlendirilmesi. Klinik Psikiyatri 2007; 10(1): 38–45.
  • Çoşkun K. Bipolar I Bozukluğu olan hastalarda karma dönemlerin ve hızlı döngülü seyrin ortaya çıkışında affektif mizaçın özelliklerinin rolü. Yayınlanmamış Uzmanlık Tezi, T.C. Sağlık Bakanlığı Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi 5. Psikiyatri Kliniği, İstanbul, 2008.
  • Mollahaliloğlu S, Kosdak M, Eryılmaz Z (editors). The Ministry of Health of Turkey Health Statistics Yearbook 2008. Ankara: Uzman Matbaacılık Yay. Kağ. Turz. İnş. San. ve Tic. Ltd. Şti, 2011, p.73–76.
  • Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990, p. 31–35.
  • Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001; 3(4): 181–8.
  • Lin CC, Bai YM, Hu PG, Yeh HS. Substance use disorders among inpatients with bipolar disorder and major depressive disorder in a general hospital. General Hosp Psychiatry 1998; 20(2): 98–101.
  • Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 2005; 67(1): 1–8.
  • Özpoyraz N, Tamam L, Şentürk A. Alkol ve Madde Kullanım Bozuklukları. Galenos Aylık Tıp Dergisi 1998; 1: 58–66.
  • Ögel K, Tamar D, Özmen E, Aker T, Sağduyu A, Boratav C, et al. İstanbul'da Alkollü İçki Kullanım Sıklığı. Psikiyatrik Araştırmalar Ve Eğitim Merkezi (PAREM), 2004.
  • Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler W. Toward a redefinition of bipolarity: epidemiology and proposed criteria for bipolar II, minor bipolar disorders and hypomania. J Affect Disord 2003; 73(1–2): 133–46.
  • Osby U, Brandt L, Correia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58(9): 844–50.
  • Jamison KR. Suicide and bipolar disorder. J Clin Psychiatry 2000; 61 (Suppl. 9): S47–S51.
  • Keck PE, McElroy SL, Arnold LM. Advances in the pathophysiology and treatment of psychiatric disorders: implications for internal medicine. Med Clin North Am 2001; 85(3): 645–61.
  • Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord 2002; 68(1): 1–23.
  • Simon NM, Otto MW, Wisniewski SR, Fossey M, Sağduyu K, Frank E, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004; 161(12): 2222–9.
  • The WHO. World Mental Health Survey Consortium Prevalence, severity, and unmet need for treatment of mental disorders in the world health organization world mental health surveys. JAM 2004; 291(21): 2581–90.
  • Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003; 64(2): 161–74.
  • Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord 2006; 8(6): 721–39.
  • Fountoulakis KN, Vieta E, Siamouli M, Valenti M, Magiria S, Oral T, et al. Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder. Ann Gen Psychiatry 2007; 6: 27.
  • Tuglu C. Antipsikotiklerin Bipolar Bozuklukta Kullanımı. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2008; 18(Suppl. 2): S50–S6.
  • Tafalla M, Sanchez-Moreno J, Diez T, Vieta E. Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode. J Affect Disord 2009; 114(1–3): 299–304.
  • Vahip S. Araştırmalardan Klinik Uygulamaya Bipolar Depresyon Tedavisi. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 1999; 9(4): 213–21.
  • Ghaemi SN. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Bipolar Disord 2008; 10(8): 957–68.
  • Şengül C, Şengül CB, Okay T, Dilbaz N. Ellibeşinci Yılında Lityumun Öyküsü. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2004; 14(1): 50–6.
  • Tomruk NB, Oral T. Elektrokonvulsif tedavinin klinik kullanımı: Bir gözden geçirme Anatolian Journal of Psychiatry 2007; 8(4): 302–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.